Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Dec 06, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-21-000018.pdf 0001883850-21-000018.xls
Dec 02, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-21-000014.pdf 0001883850-21-000014.xls
Dec 02, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-21-000016.pdf 0001883850-21-000016.xls
Nov 23, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-21-000012.pdf 0001883850-21-000012.xls
Nov 19, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-21-000009.pdf 0001883850-21-000009.xls
Nov 18, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-21-000024.pdf 0001237899-21-000024.xls
Nov 18, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-21-000088.pdf 0001708138-21-000088.xls
Nov 17, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-21-000085.pdf 0001708138-21-000085.xls
Nov 17, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-21-000086.pdf 0001708138-21-000086.xls
Nov 04, 2021	8-K	Report of unscheduled material events or corporate event	View HTML 0001804220-21-000031.pdf 0001804220-21-000031.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.

Investors & Media